Analysts: Sepracor decrease could mean cut in DTC

Share this article:

Sepracor said in reporting Q4 2007 results, 2008 revenues projected to be spent on sales, marketing and distribution expenses would likely decrease around 10% compared with 2007, despite planned launches. Analysts speculated that the decrease could mean a cut in DTC.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.

India's Marck gets FDA Warning Letter

Inspectors of Marck Biosciences found an array of problems during a October-November 2013 inspection, including mold near a sterile area that was so bad "the room had 'partially caved in.'"

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.